Targeting HCV Entry For Development of Therapeutics 英文参考文献.docVIP

Viruses 2010, 2, 1718-1733; doi:10.3390/v2081718 OPEN ACCESS viruses ISSN 1999-4915 /journal/viruses Review Targeting HCV Entry For Development of Therapeutics Flossie Wong-Staal *, Andrew J. Syder and Jeffrey F. McKelvy iTherX Pharmaceuticals, In., P.O. Box 910530, CA 910530, USA; E-Mails: dsyder@ (A.J.S.); jmckelvy@ (J.F.M.) * Author to whom correspondence should be addressed; E-Mail: fwongstaal@; Tel.: +1-858-824-1114; Fax: +1-858-824-1112. Received: 28 June 2010; in revised form: 5 August 2010 / Accepted: 16 August 2010 / Published: 18 August 2010 Abstract: Recent progress in defini